Cancer Treatment Parity Act of 2013

HR 5214 Requires the Secretary of Health and Human Services (HHS) to consult with clinical experts and make recommendations for the use of clinical data registries to improve patient care. S 1879/HR 1801 Cancer Treatment Parity Act of 2013. HR 3033 The SOFTWARE Act.

Client expense: $10,098 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152); Cancer Drug Coverage Parity Act (H.R. 1801, S. 1879).

Client expense: $440,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

21st Century Cures; HR 460, Patients' Access to Treatments Act; PPACA Marketplace Plan Network Adequacy Rules; HR 1801, Cancer Drug Coverage Parity Act; S 1879, Cancer Treatment Parity Act

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Cancer Drug Coverage Parity Act (H.R. 1801) Cancer Treatment Parity Act (S. 1879) Patients' Access to Treatments Act (H.R. 460)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

HR 1801, Cancer Drug Coverage Parity Act/S 1879 Cancer Treatment Parity Act HR 2477 Planning Actively for Cancer Treatment Act HR 2827 Part D Beneficiary Appeals Fairness Act HR 543 Blue Water Navy Vietnam Veterans Act HR 1491 Blue Water Navy Ship Accountability Act S 2844/HR 5503 James Zadroga 9/11 Health and Compensation Reauthorization Act

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act/S 1879 Cancer Treatment Parity Act HR 2477 Planning Actively for Cancer Treatment Act HR 2827 Part D Beneficiary Appeals Fairness Act HR 543 Blue Water Navy Vietnam Veterans Act HR 1491 Blue Water Navy Ship Accountability Act S 2844/HR 5503 James Zaroga 9/11 Health and Compensation Reauthorization Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S 1879 Cancer Treatment Parity Act HR 2477, Planning Actively for Cancer Treatment Act HR 2827, Part D Beneficiary Appeals Fairness Act HR 543, Blue Water Navy Vietnam Veterans Act HR 1491, Blue Water Navy Ship Accountability Act S 2844/HR 5503, James Zadroga 9/11 Health and Compensation Reauthorization Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment parity Act of 2013 (S. 1879); and Patients Access to Treatment Act (H.R. 460).

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Cancer Drug Coverage Parity Act (H.R. 1801, S. 1879).

Client expense: $400,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5214 Requires the Secretary of Health and Human Services (HHS) to consult with clinical experts and make recommendations for the use of clinical data registries to improve patient care. S 1879/HR 1801 Cancer Treatment Parity Act of 2013. HR 3033 The SOFTWARE Act.

Client expense: $36,316 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Cancer Drug Coverage Act (H.R. 1801); Cancer Treatment Parity Act of 2013 (S. 1879); and Patients Access to Treatment Act (H.R. 460).

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S 1879 Cancer Treatment Parity Act HR 2477, Planning Actively for Cancer Treatment Act HR 2827, Part D Beneficiary Appeals Fairness Act HR 543, Blue Water Navy Vietnam Veterans Act HR 1491, Blue Water Navy Ship Accountability Act S 2844/HR 5503, James Zadroga 9/11 Health and Compensation Reauthorization Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 460, Patient Access to Treatment Act; HR 1801 Cancer Drug Coverage Parity Act/S. 1879 Cancer Treatment Parity Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S 1879 Cancer Treatment Parity Act HR 2477, Planning Actively for Cancer Treatment Act HR 2827, Part D Beneficiary Appeals Fairness Act HR 543, Blue Water Navy Vietnam Veterans Act HR 1491, Blue Water Navy Ship Accountability Act H.R. 5503, James Zadroga 9/11 Health and Compensation Reauthorization Act

Client expense: $63,500 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Cancer Drug Coverage Parity Act (H.R. 1801, S. 1879). Issues related to the Veterans Access to Care Act (H.R. 4810, S. 2450).

Client expense: $470,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act of 2013 (S. 1879); Patients Access to Treatment Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES

HR 1801 Cancer Drug Coverage Parity Act / S 1879 Cancer Treatment Parity Act HR 2477 Planning Actively for Cancer Act HR 2827 Part D Beneficiary Appeals Fairness Act HR 543 Blue Water Navy Vietnam Veterans Act HR 1491 Blue Water Navy Ship Accountability Act

Client expense: $53,500 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S 1879 Cancer Treatment Parity Act HR 2477, Planning Actively for Cancer Treatment Act HR 2827, Part D Beneficiary Appeals Fairness Act HR 543, Blue Water Navy Vietnam Veterans Act HR 1491, Blue Water Navy Ship Accountability Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 460 Patient Access to Treatment Act; HR 1801 Cancer Drug Coverage Parity Act/S 1879 Cancer Treatment Parity Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Cancer Drug Coverage Parity Act (H.R. 1801, S. 1879).

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act of 2013 (S. 1879); Patients Access to Treatment Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Cancer Drug Coverage Parity Act, H.R.1801/S.1879 Cancer Treatment Parity Act

Client expense: $49,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1801, Cancer Drug Coverage Parity Act/S. 1879 Cancer Treatment Parity Act H.R. 2477, Planning Actively for Cancer Treatments Act H.R. 2827, Part D Beneficiary Appeals Fairness Act H.R. 543, Blue Water Navy Vietnam Veterans Act H.R. 1491, Blue Water Navy Ship Accountability Act

Client expense: $49,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implimentation of The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S. 1879 Cancer Treatment Parity Act HR 2477, Planning Actively for Cancer Treatment Act HR 2827, Part D Beneficiary Appeals Fairness Act HR 543 Blue Water Navy Vietnam Veterans ActHR 1491, Blue Water Navy Ship Accountability Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Cancer Drug Coverage Parity Act, H.R. 1801/ S. 1879 Cancer Treatment Parity Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801/S 1879 Cancer Drug Coverage Parity Act of 2013

Client expense: $37,725 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1801, Cancer Drug Coverage Parity Act. S. 1879, Cancer Treatment Parity Act of 2013 H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 3680, Breast Cancer Awareness Commemorative Coin Act Pub. Law No. 113-54, Drug Quality and Security Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

HR 1801, Cancer Drug Coverage Parity Act/S.1879, Cancer Treatment Parity Act HR 3204, Drug Quality and Security Act/S959, Pharmaceutical Quality, Security &Accountability HR 2477, Planning Actively for Cancer Treatment Act

Client expense: $47,500 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1801, Cancer Drug Coverage Parity Act/S.1879, Cancer Treatment Parity Act

Client expense: $47,500 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S. 1879 Cancer Treatment Parity Act HR 3204, Drug Quality & Security Act/S 959 Pharmaceutical Quality, Security & Accountability Act HR 2477, Planning Actively for Cancer Treatment Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Cancer Drug Coverage Parity Act, H.R. 1801/ S. 1879 Cancer Treatment Parity Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE